Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emerald Seed Products is a Canadian biotechnology company that specializes in the processing and extraction of bioactive components from fenugreek seeds. The company employs a proprietary, chemical-free aqueous extraction process to produce standardized ingredients for both the animal health and human nutraceutical industries. Their primary product, Nutrifen, is a natural feed additive designed to improve digestive health and growth performance in livestock such as swine and poultry. For human health, the company focuses on extracts that support metabolic functions, particularly blood glucose management. Based in Saskatchewan, Emerald Seed Products bridges the gap between traditional agriculture and advanced life sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emerald Seed Products.